|
- Home | Breyanzi® (lisocabtagene maraleucel) CAR T Cell Therapy
Breyanzi® (lisocabtagene maraleucel) CAR T cell therapy treatment is a one-time infusion used to treat adult patients with large B-cell lymphoma (LBCL), chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), follicular lymphoma (FL), and mantle cell lymphoma (MCL)
- Is Breyanzi® (lisocabtagene maraleucel) right for me?
Breyanzi is a one-time infusion * made from your own white blood cells (T cells) It may be an option, even if other treatments have not worked or stopped working—so talk to your doctor to see if it is right for you
- Starting Breyanzi® (lisocabtagene maraleucel)
BREYANZI is different than other cancer medicines because it is made from your own white blood cells, which have been genetically modified to recognize and attack your lymphoma cells
- Large B-Cell Lymphoma Results (LBCL) - BREYANZI
BREYANZI is different than other cancer medicines because it is made from your own white blood cells, which have been genetically modified to recognize and attack your lymphoma cells
- Treatment Journey Resources | Breyanzi® (lisocabtagene maraleucel)
Access downloadable resources for Breyanzi® (lisocabtagene maraleucel) including a treatment brochure and a doctor discussion guide Please see full Prescribing Information, including Boxed WARNINGS and Medication Guide
- CAR T Cell Therapy for Large B-Cell Lymphoma - breyanzi. com
BREYANZI is different than other cancer medicines because it is a prescription medicine made from your own white blood cells and given as an intravenous (IV) infusion
- Find a CAR T Cell Therapy Treatment Center | Breyanzi® (lisocabtagene . . .
Use the CAR T cell therapy treatment locator by Breyanzi® (lisocabtagene maraleucel) to find a certified treatment center near you Please see full Prescribing Information, including Boxed WARNINGS and Medication Guide
- Large B-cell lymphoma (LBCL) Remission is Possible. Powered . . . - Breyanzi
BREYANZI is different than other cancer medicines because it is made from your own white blood cells, which have been genetically modified to recognize and attack your lymphoma cells
|
|
|